Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association
-
Saudi J Gastroenterol · May 2017
Randomized Controlled TrialRole of N-acetylcysteine treatment in non-acetaminophen-induced acute liver failure: A prospective study.
Acute liver failure (ALF) is a rare but severe medical emergency. To date, there is no established treatment for non-acetaminophen-induced acute liver failure (NAI-ALF) other than liver transplantation, and little is known about the use of N-acetylcysteine (NAC) in NAI-ALF. A randomized case control study was conducted with the aim to determine the effect of NAC on the mortality of NAI-ALF patients, as well as to evaluate the safety and efficacy of NAC use. ⋯ The findings of the study recommend the use of NAC along with conventional treatments in patients with NAI-ALF in non-transplant centers while awaiting referrals and conclude the use of NAC as safe.